FDA Commissioner Scott Gottlieb Comments on Premium Cigars and Regulation
The recently appointed new head of the U.S. Food & Drug Administration (FDA), Dr. Scott Gottlieb, made some of his first public comments about...
Texas Cigar Businesses Sue FDA Over Warning Label Regulations
Three Texas-based cigar businesses have filed a new lawsuit against the U.S. Food and Drug Administration (FDA). This new lawsuit specifically targets the FDA’s...
Tobacco 21 Ordinance Defeated in Kansas’ Shawnee County – Who’s Next?
2017 saw many local governments introducing legislation that raised the legal age to buy tobacco products from 18 to 21. Now a battle is...
Tobacco 21 is a Catch-22
A Catch-22 is a problematic situation caused by mutually conflicting or seemingly contradictory conditions. Considering raising the legal age to purchase tobacco products is...
IPCPR and CRA File Joint ANPRM Comment for Premium Cigar Industry
Two major cigar trade associations teamed up to file a response to the U.S. Food and Drug Administration's (FDA) advance notice of proposed rule...
FDA Issues Proposed Guidance on Sampling Ban
The U.S. Food and Drug Administration (FDA)’s Center for Tobacco Products released a proposed guidance document describing the agency’s recommendations on how retailers, manufacturers...
FDA’s Nicotine Warning Statement Requirement Goes Into Effect Aug. 10, 2018
There's a deadline looming that is catching some tobacco manufacturers and retailers by surprise. Starting on Aug. 10, 2018, nicotine warning labels will be...
Congress Close to Passing National Tobacco 21 Legislation
To round out a year of industry-changing legislation, Congress is reportedly on the verge of permanently raising the minimum age for purchasing tobacco products...
NATO: FDA Requests Courts to Extend PMTA Application Deadline
The following article was submitted by the National Association of Tobacco Outlets (NATO)
Yesterday, the U.S. Department of Justice (DOJ), on behalf of the U.S....
FDA Extends Commenting Period for Substantial Equivalence Draft Guidance
The U.S. Food and Drug Administration (FDA) has announced that it has extended the commenting period for the agency's draft guidance on Substantial Equivalence...
